Pular para o conteúdo

NAH: First Commercial Precision Dosing Model for Heparin

Today, InsightRX and Northern Arizona Healthcare (NAH) announced they will make InsightRX’s precision dosing software for heparin therapy available to NAH’s pharmacists at Flagstaff Medical Center. NAH expects this deployment to decrease the time it takes to therapeutically dose hospitalized patients with unfractionated heparin to treat and prevent blood clots, improving patient outcomes.

NAH is a multi-site, not-for-profit health system that views precision dosing as a transformative approach for advancing medical practice and recognizes InsightRX’s continuous learning platform as the solution for clinicians to standardize high-quality care practices.

avatar do autor
LabNews Media LLC
Os Editores-Chefes do labnews.ai são Marita Vollborn e Vlad Georgescu. Eles são autores best-sellers, escritores de ciência e jornalistas científicos desde 1994.Mais detalhes sobre sua escrita no X-Press Journalistenbüro (https://xpress-journalisten.com).Mais informações na Wikipedia:Sobre Marita: https://de.wikipedia.org/wiki/Marita_Vollborn Sobre Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu
LabNews Media LLC

LabNews Media LLC

Os Editores-Chefes do labnews.ai são Marita Vollborn e Vlad Georgescu. Eles são autores best-sellers, escritores de ciência e jornalistas científicos desde 1994.Mais detalhes sobre sua escrita no X-Press Journalistenbüro (https://xpress-journalisten.com).Mais informações na Wikipedia:Sobre Marita: https://de.wikipedia.org/wiki/Marita_Vollborn Sobre Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu